Page last updated: 2024-10-17

gallic acid and Coronary Disease

gallic acid has been researched along with Coronary Disease in 2 studies

gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research Excerpts

ExcerptRelevanceReference
"Propyl gallate (1 mg/kg/h) was infused in anesthetized cats 0."1.27Protective actions of propyl gallate, a lipoxygenase inhibitor, on the ischemic myocardium. ( Lefer, AM; Leprán, I, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leprán, I1
Lefer, AM1
Yokoyama, H1

Other Studies

2 other studies available for gallic acid and Coronary Disease

ArticleYear
Protective actions of propyl gallate, a lipoxygenase inhibitor, on the ischemic myocardium.
    Circulatory shock, 1985, Volume: 15, Issue:2

    Topics: Animals; Arachidonic Acids; Cats; Coronary Disease; Creatine Kinase; Gallic Acid; Lipoxygenase Inhib

1985
[Clinical physiopathological studies on myocardial oxygen metabolism. 3. Myocardial oxygen metabolism during administration of coronary dilators].
    Japanese circulation journal, 1971, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Aged; Benzoates; Benzofurans; Coronary Disease; Coumarins; Dipyridamole; Female;

1971